References

Meta-analytical studies on new antidepressants

10.1093/bmb/57.1.161 · 2001 · External reference

Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder

10.1185/030079907x159498 · 2007 · External reference

Fluoxetine in tricyclic refractory major depressive disorder

10.1016/0165-0327(90)90144-w · 1990 · External reference

A double-blind comparison of escitalopram and paroxetine in the long-term treatment of generalized anxiety disorder

10.1080/10401230590932326 · 2005 · External reference

Venlafaxine extended release in post-traumatic stress disorder: a sertraline- and placebo-controlled study

10.1097/01.jcp.0000222514.71390.c1 · 2006 · External reference

Duloxetine in the acute and long-term treatment of major depressive disorder : a placebo- and paroxetine-controlled trial

10.1016/j.euroneuro.2004.01.002 · 2004 · External reference

Neuroimaging studies of mood disorders

10.1016/s0006-3223(00)01020-9 · 2002 · External reference

Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy

2005 · External reference

A method for controlling for a high placebo response rate in a comparison of venlafaxine XR and diazepam in the short-term treatment of patients with generalised anxiety disorder

10.1016/s0924-9338(03)00046-4 · 2003 · External reference

A susceptibility gene for affective disorders and the reponse of the human amygdala

10.1001/archpsyc.62.2.146 · 2005 · External reference

Antidepressant treatment of depression : a meta-analysis

10.1177/070674379604101002 · 1996 · External reference

Comparison of venlafaxine extended release versus paroxetine for treatment of patients with generalized anxiety disorder

10.1111/j.1440-1819.2006.01512.x · 2006 · External reference

SAD Study Group. A randomized controlled trial of venlafaxine extended release in generalized social anxiety disorder

10.4088/jcp.v66n0213 · 2005 · External reference

Potential Treatment Paradigms for Anxiety Disorders Expert Opinion on Investigational

1999 · External reference

Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression

10.1097/00004850-199300830-00009 · 1993 · External reference

Can’t shake that feeling: event-related f MRI assessment of subtained amygdala activity in response to emotional information in depressed individuals

10.1016/s0006-3223(02)01314-8 · 2002 · External reference

Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder

10.4088/jcp.v62n07a04 · 2001 · External reference

SNRIs : their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants

10.1017/s1092852900019726 · 2005 · External reference